Versant Venture Capital VI, L.P. - 12 Nov 2024 SCHEDULE 13D/A Report for Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST)

Filing manager
Versant Venture Capital VI, L.P.
Reporting owner
Versant Vantage II, L.P.
Security
Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share
Beneficially owned shares
2,118,644 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

4.8%

Beneficial ownership of this reported class.

Shares

2,118,644 shares

Shares beneficially owned as disclosed.

Event date

12 Nov 2024

Date tied to the ownership event or amendment.

Accepted by SEC

11 Feb 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
4.8%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
TPST
Shares outstanding
44,138,417 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
11 Feb 2025, 17:58:53 UTC
Event date
12 Nov 2024
Next SEC filing
13 Aug 2025
Source filing
View source filing

Key filing fact

Versant Venture Capital VI, L.P. disclosed 4.8% ownership in Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST) on 12 Nov 2024.

Key facts

  • Versant Venture Capital VI, L.P. filed SCHEDULE 13D/A for Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST).
  • Disclosed ownership: 4.8%.
  • Date of event: 12 Nov 2024.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Feb 2025, 17:58.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (9)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Versant Venture Capital VI, L.P. 0.5% 209,914 209,914 0 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Ventures VI GP-GP, LLC, the General Partner of Versant Ventures VI GP, L.P. 0001687880
Versant Ventures VI GP, L.P. 0.5% 209,914 0 209,914 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Ventures VI GP-GP, LLC, the General Partner of Versant Ventures VI GP, L.P. 0001777654
Versant Ventures VI GP-GP, LLC 0.5% 209,914 0 209,914 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer 0001777652
Versant Vantage II, L.P. 4.8% 2,118,644 2,118,644 0 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Ventures II GP-GP, LLC, the General Partner of Versant Vantage II GP, L.P., the General Partner of Ve 0001832235
Versant Vantage II GP, L.P. 4.8% 2,118,644 0 2,118,644 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Vantage II GP-GP, LLC, the General Partner of Versant Vantage II GP, L.P. 0001839790
Versant Vantage II GP-GP, LLC 4.8% 2,118,644 0 2,118,644 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer 0001839789
Versant Venture Capital IV, L.P. 2.7% 1,171,094 1,171,094 0 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Ventures IV, LLC, the General Partner of Versant Venture Capital IV, L.P. 0001456590
Versant Side Fund IV, L.P. 0% 7,377 7,377 0 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer of Versant Ventures IV, LLC, the General Partner of Versant Side Fund IV, L.P. 0001456591
Versant Ventures IV, LLC 2.7% 1,178,471 0 1,178,471 /s/Max Eisenberg Max Eisenberg/Chief Operating Officer
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .